source
- Mentari Therapeutics to go public via reverse merger with InMed, raising $290 million for migraine antibody programsMentari Therapeutics, a spinout of Paragon, announced a reverse merger with InMed Pharmaceuticals that will take the company public under the Mentari name. The deal has received board approval fro…
- Virginia Governor Vetoes Bill to Create Drug-Cost Advisory Panel Using Medicare BenchmarksVirginia's governor, Abigail Spanberger, vetoed a bill that would have created a new advisory panel aimed at lowering prescription-drug costs. The legislation had been closely watched as a potentia…